Infectious Disease · Medical Literature

[Editorial] “A world on the edge” as preparedness hopes waver

Abstract

A year ago, we expressed cautious hope at the adoption of the WHO Pandemic Agreement during the 78th World Health Assembly, with the caveat that strengthening local health systems, international cooperation, and establishing sustainable financing mechanisms would be indispensable for the success of any pandemic preparedness plan. Although we maintain the importance of having reached this Agreement, and of the commitment made at the 79th World Health Assembly (May 18–23, 2026) to continue negotiating its Pathogen Access and Benefit Sharing annex, the 2026 report of the Global Preparedness Monitoring Board (GPMB)—ominously titled A world on the edge—is disheartening, if somewhat unsurprising.

Clinical relevance

Does the current state of global pandemic preparedness infrastructure — including international agreements, financing mechanisms, and health system capacity — adequately protect the world against the rising frequency and severity of infectious disease outbreaks? __SNAPSHOT__ {"studyDesign":"Expert editorial / policy commentary — not a primary research study; no hypothesis testing, randomization, or original data collection. The editorial responds to and contextualizes the 2026 Global Preparedness Monitoring Board (GPMB) annual report.","setting":"Global; authored by The Lancet Microbe editorial board in response to the 2026 GPMB report released at the 79th World Health Assembly (May 18–23, 2026), Geneva, Switzerland.","sampleSize":"Not applicable (editorial). The referenced GPMB report draws on a monitoring framework of 90 indicators across three dimensions, with multisectoral data spanning member states.","population":"Global population; all nations subject to pandemic risk, with particular concern for low- and middle-income countries and populations with limited access to health system infrastructure and medical countermeasures.","intervention":"Adoption and ongoing negotiation of the WHO Pandemic Agreement (adopted at the 78th World Health Assembly) and its Pathogen Access and Benefit Sharing (PABS) annex, alongside strengthening of local health systems, international cooperation, and sustainable pandemic financing mechanisms.","comparator":"Not applicable (editorial commentary). Implicit comparator is the unfulfilled preparedness baseline anticipated following COVID-19 and prior GPMB recommendations.","primaryOutcome":"Not applicable (editorial). Central concern is whether commitments embedded in the WHO Pandemic Agreement and multilateral frameworks are being translated into measurable improvements in global pandemic preparedness, equitable access to countermeasures, and sustainable financing.","followUp":"Not applicable (editorial). The GPMB 2026 report analyzes trends across a decade of Public Health Emergencies of International Concern (PHEICs), from the 2014 West African Ebola epidemic through COVID-19 to mpox.","fundingSource":"The Lancet Microbe (publisher-funded editorial). The underlying GPMB 2026 report was financially supported by the Gates Foundation and the Institute of Philanthropy, with WHO hosting the GPMB Secretariat."}

Key findings

This editorial does not report original quantitative findings. Its central argument — grounded in the GPMB 2026 report — is that pandemic preparedness is deteriorating despite post-COVID investments and international agreements. Key data points cited from the GPMB report: (1) In 2024, WHO detected nearly twice as many health emergency events as in 2015, yet outbreaks that breach containment have become higher-impact events. (2) Global deaths from infectious diseases declined from 25% of all-cause mortality in 2000 to 15% in 2015, but rose to 23% in 2021 driven by COVID-19; absent COVID-19, infectious disease mortality would have been approximately 11%. (3) Development assistance for pandemic preparedness has fallen to levels not seen since 2009, effectively erasing gains made over two decades. (4) The GPMB Monitoring Framework (90 indicators, three dimensions) found that pandemic prevention and preparedness is not keeping pace with changing risks. (5) Geopolitical fragmentation, ecological disruption, expanded global travel, and eroding trust between governments, citizens, and multilateral institutions compound structural vulnerabilities. No p-values, confidence intervals, or effect sizes are reported in the editorial or its abstract. All quantitative figures above are drawn from the GPMB 2026 source report as referenced by the editorial.

Practice implications

This editorial establishes that the adoption of the WHO Pandemic Agreement, while a meaningful diplomatic achievement, has not yet translated into the operational strengthening of health systems, equitable access to diagnostics/vaccines/therapeutics, or sustainable financing that would substantively reduce pandemic risk. It does not establish causation between any specific policy or intervention and preparedness outcomes, nor does it report clinical trial data. The findings apply to global health policymakers, national governments, international health agencies, and clinicians engaged in infectious disease preparedness planning. Frontline clinicians — particularly those in infectious disease, public health, emergency medicine, and primary care — should understand that the structural weaknesses identified (underfunded surveillance, inequitable countermeasure access, fragmented international cooperation) directly shape the epidemiological environment in which they practice. The editorial is available only in abstract form for this summary; the full text may contain additional nuance, supporting references, or editorial positions not captured here. Readers are encouraged to access the full editorial and the GPMB 2026 report directly for comprehensive interpretation. __LIMITATIONS__ As an editorial, this document is inherently subject to the following limitations: (1) No primary data are generated; conclusions rely entirely on the GPMB 2026 report and the editorial board's interpretive framework. (2) The GPMB report itself is based on monitoring indicators rather than randomized or quasi-experimental data, limiting causal inference regarding which preparedness investments work. (3) Indicator-based frameworks (90 indicators across three dimensions) may not capture the full heterogeneity of national preparedness contexts or adequately weight the most clinically consequential gaps. (4) Editorial tone may reflect normative policy preferences of the authorship that go beyond what the underlying data strictly support. (5) Generalizability is inherently constrained: aggregate global trends may mask important regional, national, and sub-national variation. (6) Partial funding of the GPMB report by the Gates Foundation and the Institute of Philanthropy introduces a potential, if indirect, conflict of interest that warrants acknowledgment when interpreting recommendations. (7) The distinction between statistical associations identified in GPMB monitoring data and clinically or epidemiologically actionable conclusions is not rigorously drawn in an editorial format. __BOTTOM_LINE_CATEGORY__ low_certainty __BOTTOM_LINE__ The 2026 GPMB report, as interpreted by this Lancet Microbe editorial, provides strong monitoring-based evidence that global pandemic preparedness is regressing relative to rising infectious disease risk, with development assistance at its lowest point since 2009, eroding trust in multilateral institutions, and inequitable access to countermeasures persisting as a structural failure. The WHO Pandemic Agreement represents a necessary but insufficient step; its impact will depend entirely on whether nations convert diplomatic commitments into funded, operational, and equitable preparedness systems. Clinicians should advocate for domestic health system investment and familiarize themselves with the GPMB recommendations, as the next high-impact pathogen event will test the preparedness gaps this editorial describes.

Evidence appraisal

Evidence quality rating
5/10
Clinical applicability score
5/10